The Influence of Dopamine Agonist Cabergoline on Oocyte Maturation in Women Undergoing Assisted Reproduction.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2013
At a glance
- Drugs Cabergoline (Primary)
- Indications Ovarian hyperstimulation syndrome
- Focus Pharmacodynamics
- 20 Jul 2011 Actual end date (July 2011) added as reported by ClinicalTrials.gov.
- 20 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Apr 2011 Status changed from discontinued to active, no longer recruiting as reported by ClinicalTrials.gov.